The founders.

Daniel William Dorsey

Co-founder and Chief Executive Officer of Atumnus Life Sciences. Twenty years building technology companies across regulated industries — medical devices, legal technology, distribution, and cybersecurity. Background in engineering software systems and technical product development.

Designed the OptiOral Care program — a category Atumnus created, not entered — around a dual-value structure that generates recurring federal tax credit revenue for enrolled practices while simultaneously building the multi-site clinical dataset required for peer-reviewed publication. Leads investor relations, capital strategy, and IP positioning across five independent patent layers covering the dental, longevity, naturopathic, and homeopathic verticals under a single research infrastructure.

Holds HI-Centric-AI as the working philosophy underneath the practice — a discipline he speaks for as a practitioner, not a theorist.

“Artificial intelligence built around human thinking isn't a new idea. Wiener saw it in 1948, Engelbart in 1962, Polanyi in 1966. What this generation hasn't had is a contemporary version — a working philosophy that takes the older thought seriously and brings it into the professions where the human at the center of the work actually matters. HI-Centric-AI is that. Offered to be inherited, not defended.”

Daniel Nowak

Co-founder and Chief Technology Officer of Atumnus Life Sciences. Fifteen years in distributed systems and machine learning. Former engineering lead at enterprise software companies. Specializes in AI infrastructure for compliance-heavy industries.

Designed and built the full technology infrastructure underlying OptiOral Care — a proprietary documentation platform that captures IRS-defensible qualified research expense data at point of care, timestamped and provider-attributed, satisfying the mandatory Form 6765 Section G project-level reporting requirements that became enforceable in 2026.

Background spans full-stack systems architecture, adaptive intelligence agent orchestration, and applied infrastructure across healthcare, scientific research, and financial intelligence. Has shipped production systems across dental technology, adaptive intelligence inference infrastructure, and clinical data pipelines — engineering execution that most life sciences companies outsource and never own.